Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site: Complete Statistical AnalysisIndependent statistical analysis of Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Utilization of Confocal Microscopy During Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Utilization of Confocal Microscopy During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03189134).
- Utilization of Hepatitis C Positive Kidneys in Negative Recipients: Complete Statistical AnalysisIndependent statistical analysis of Utilization of Hepatitis C Positive Kidneys in Negative Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03801707).
- Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- UVIndependent statistical analysis of Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- UVA-Gen001Independent statistical analysis of Study of Genistein in Pediatric Oncology Patients (UVA-Gen001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02624388).
- V-CAMSIndependent statistical analysis of CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03584386).
- V-DIFFERENCEIndependent statistical analysis of Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia: primary endpoint…
- V-EXTRA-CVDIndependent statistical analysis of A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- V-PAXIndependent statistical analysis of Vaping THC From Electronic Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955329).
- V2 Receptor Effects on Fluid Regulation and Performance: Complete Statistical AnalysisIndependent statistical analysis of V2 Receptor Effects on Fluid Regulation and Performance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02084797).
- V2VIndependent statistical analysis of Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028): Complete Statistical AnalysisIndependent statistical analysis of V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- V710 First-In-Man (FIM) Study (V710-001): Complete Statistical AnalysisIndependent statistical analysis of V710 First-In-Man (FIM) Study (V710-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00303069).
- VA CARDSIndependent statistical analysis of Coronary Artery Revascularization in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00326196).
- VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV: Complete Statistical AnalysisIndependent statistical analysis of VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01158157).
- VA-TECIndependent statistical analysis of Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01855399).
- VAC 2006-19Independent statistical analysis of A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds: primary endpoint results, effect estimate with…
- VAC-OFIndependent statistical analysis of Vacuum Assisted Closure as a Treatment for Open Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00582361).
- VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines: Complete Statistical AnalysisIndependent statistical analysis of VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF: Complete Statistical AnalysisIndependent statistical analysis of Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01635283).
- Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2): Complete Statistical AnalysisIndependent statistical analysis of Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01119703).
- Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00070070).
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001): Complete Statistical AnalysisIndependent statistical analysis of Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02269423).
- Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds: Complete Statistical AnalysisIndependent statistical analysis of Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02803164).
- VAD00001Independent statistical analysis of Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval,…
- Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03189446).
- Vaginal Cuff Dehiscence and Thermal Injury During TLH: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Cuff Dehiscence and Thermal Injury During TLH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080546).
- Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaginal Preparation Prior to Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Preparation Prior to Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03412734).
- Vagus Nerve Stimulation (VNS) Paired With Tones for Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of Vagus Nerve Stimulation (VNS) Paired With Tones for Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01962558).
- Vagus Nerve Stimulation and Stress Reduction Training for Migraine: Complete Statistical AnalysisIndependent statistical analysis of Vagus Nerve Stimulation and Stress Reduction Training for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03592329).
- Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations: Complete Statistical AnalysisIndependent statistical analysis of Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VAL201-001Independent statistical analysis of Dose Finding Safety Study of VAL201 in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02280317).
- Valacyclovir in Neonatal Herpes Simplex Virus Disease: Complete Statistical AnalysisIndependent statistical analysis of Valacyclovir in Neonatal Herpes Simplex Virus Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04448392).